Novel THAP1 missense variant with incomplete penetrance in a case of generalized young onset dystonia showing good response to deep brain stimulation

Ignacio J. Keller Sarmiento, Avram Fraint, Lisa Kinsley, Rizwan S. Akhtar, Vincenzo Silani, Steven J. Lubbe, Dimitri Krainc, Niccolò E. Mencacci*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

We describe a case of young onset generalized dystonia, harboring a previously unreported likely pathogenic THAP1 missense variant (c.109 G > A; p.Glu37Lys) that was inherited from her unaffected father. Moreover, we report a positive effect of deep brain stimulation, particularly on the cervical component of dystonia.

Original languageEnglish (US)
Pages (from-to)7-8
Number of pages2
JournalParkinsonism and Related Disorders
Volume105
DOIs
StatePublished - Dec 2022

Funding

N.E.M. is funded by a Parkinson's Foundation grant. I.J.K.S. is supported by the Align Sience Across Parkinson's (ASAP) Global Parkinson's Genetics Program (GP2). To investigate a possible genetic etiology, an extensive panel for dystonia was ordered, which identified a previously unreported variant in THAP1 (NM_018105.2; exon 2 c.109 G > A; p.Glu37Lys), inherited from her unaffected father. Only one carrier (1/125,682) is reported in the genome aggregation database (gnomAD v2.1.1; https://gnomad.broadinstitute.org/). Whole-exome sequencing was additionally performed as reported elsewhere [3]. This analysis excluded additional relevant pathogenic variants in an extended list of genes linked to movement disorders or other de novo or bi-allelic variants in novel candidate disease-associated genes (Supplemental Table 1). According to ACMG/AMP guidelines, this variant is classified as likely pathogenic, meeting 2 moderate evidence (PM1, PM2) and 2 supporting evidence criteria (PP3, PP4) [4].V.S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon. Receives or has received research supports form the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology.N.E.M. is funded by a Parkinson's Foundation grant.

Keywords

  • Deep brain stimulation
  • Generalized dystonia
  • Incomplete penetrance
  • Pathogenic variant
  • THAP1

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Novel THAP1 missense variant with incomplete penetrance in a case of generalized young onset dystonia showing good response to deep brain stimulation'. Together they form a unique fingerprint.

Cite this